|
WO2009082686A1
|
|
Compositions and methods for using asymmetric disulfides
|
|
US2006275836A1
|
|
Methods of identifying respondents to hypoxia inducible factor 1-α inhibitors
|
|
CA2577312A1
|
|
Method of pre-selecting patients for anti-vegf, anti hif-1 or anti-thioredoxin therapy
|
|
US2006063824A1
|
|
Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
|
|
MXPA05004845A
|
|
N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor.
|
|
US6372772B1
|
|
Inhibitors of redox signaling and methods of using same
|
